Sonova H Ag - Asset Resilience Ratio
Sonova H Ag (SOON) has an Asset Resilience Ratio of 0.03% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2005–2026)
This chart shows how Sonova H Ag's Asset Resilience Ratio has changed over time. Check SOON capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Sonova H Ag's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Sonova H Ag.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CHF0.00 | 0% |
| Short-term Investments | CHF1.90 Million | 0.03% |
| Total Liquid Assets | CHF1.90 Million | 0.03% |
Asset Resilience Insights
- Limited Liquidity: Sonova H Ag maintains only 0.03% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Sonova H Ag Industry Peers by Asset Resilience Ratio
Compare Sonova H Ag's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
GN Store Nord
CO:GN |
Medical Devices | -4.56% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 39.15% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317 |
Medical Devices | 10.88% |
|
Beijing Succeeder Technology Inc
SHG:688338 |
Medical Devices | 28.27% |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932 |
Medical Devices | 34.47% |
|
Stratec SE
XETRA:SBS |
Medical Devices | 0.30% |
Annual Asset Resilience Ratio for Sonova H Ag (2005–2026)
The table below shows the annual Asset Resilience Ratio data for Sonova H Ag.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2026-03-31 | 0.03% | CHF1.90 Million ≈ $2.40 Million |
CHF5.63 Billion ≈ $7.12 Billion |
-3.77pp |
| 2025-03-31 | 3.80% | CHF225.40 Million ≈ $284.97 Million |
CHF5.92 Billion ≈ $7.49 Billion |
+3.80pp |
| 2024-03-31 | 0.01% | CHF400.00K ≈ $505.71K |
CHF5.79 Billion ≈ $7.32 Billion |
-0.02pp |
| 2023-03-31 | 0.03% | CHF1.40 Million ≈ $1.77 Million |
CHF5.55 Billion ≈ $7.02 Billion |
-2.69pp |
| 2022-03-31 | 2.72% | CHF151.90 Million ≈ $192.04 Million |
CHF5.59 Billion ≈ $7.06 Billion |
-20.09pp |
| 2021-03-31 | 22.81% | CHF1.35 Billion ≈ $1.71 Billion |
CHF5.93 Billion ≈ $7.49 Billion |
+22.74pp |
| 2020-03-31 | 0.07% | CHF3.30 Million ≈ $4.17 Million |
CHF4.49 Billion ≈ $5.67 Billion |
-1.36pp |
| 2019-03-31 | 1.44% | CHF61.70 Million ≈ $78.01 Million |
CHF4.29 Billion ≈ $5.43 Billion |
-1.75pp |
| 2018-03-31 | 3.19% | CHF137.34 Million ≈ $173.63 Million |
CHF4.30 Billion ≈ $5.44 Billion |
+1.06pp |
| 2017-03-31 | 2.13% | CHF83.91 Million ≈ $106.09 Million |
CHF3.94 Billion ≈ $4.98 Billion |
+2.06pp |
| 2016-03-31 | 0.07% | CHF1.92 Million ≈ $2.42 Million |
CHF2.75 Billion ≈ $3.48 Billion |
-0.13pp |
| 2015-03-31 | 0.20% | CHF5.45 Million ≈ $6.89 Million |
CHF2.69 Billion ≈ $3.40 Billion |
+0.05pp |
| 2014-03-31 | 0.15% | CHF3.97 Million ≈ $5.02 Million |
CHF2.59 Billion ≈ $3.28 Billion |
-0.02pp |
| 2013-03-31 | 0.17% | CHF4.64 Million ≈ $5.87 Million |
CHF2.68 Billion ≈ $3.39 Billion |
-0.12pp |
| 2012-03-31 | 0.30% | CHF6.80 Million ≈ $8.60 Million |
CHF2.29 Billion ≈ $2.89 Billion |
-1.02pp |
| 2011-03-31 | 1.32% | CHF28.59 Million ≈ $36.14 Million |
CHF2.17 Billion ≈ $2.75 Billion |
+0.59pp |
| 2010-03-31 | 0.73% | CHF17.55 Million ≈ $22.19 Million |
CHF2.41 Billion ≈ $3.05 Billion |
-0.30pp |
| 2009-03-31 | 1.03% | CHF14.66 Million ≈ $18.54 Million |
CHF1.43 Billion ≈ $1.80 Billion |
-0.24pp |
| 2008-03-31 | 1.27% | CHF16.19 Million ≈ $20.47 Million |
CHF1.27 Billion ≈ $1.61 Billion |
-3.79pp |
| 2007-03-31 | 5.07% | CHF64.00 Million ≈ $80.92 Million |
CHF1.26 Billion ≈ $1.60 Billion |
+3.69pp |
| 2006-03-31 | 1.38% | CHF12.76 Million ≈ $16.13 Million |
CHF928.12 Million ≈ $1.17 Billion |
-0.29pp |
| 2005-03-31 | 1.67% | CHF12.40 Million ≈ $15.68 Million |
CHF743.36 Million ≈ $939.81 Million |
-- |
About Sonova H Ag
Sonova Holding AG manufactures and sells hearing care solutions for children and adults in Switzerland, the United States, rest of the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates through Hearing Instruments, Cochlear Implants, and Lifestyle-Aligned segments. The Hearing Instruments segment engages in the design, development, manufacture, distribution, and service … Read more